Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region

NCT ID: NCT02767648

Last Updated: 2016-05-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

57 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-05-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the study is to characterize the epidemiologic data of the neonatal and infant cholestasis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholestasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cholestasis

infant suffering from cholestasis proteomic urine analysis

proteomic urine analysis

Intervention Type OTHER

proteomic urine analysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

proteomic urine analysis

proteomic urine analysis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infant \<1 year suffering from cholestasis

Exclusion Criteria

* Rejection or inability for parent to give their informed consent
Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre Broue, MD

Role: PRINCIPAL_INVESTIGATOR

UH Toulouse

Thierry Lamireau, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Bordeaux

Jane Languepin, MD

Role: PRINCIPAL_INVESTIGATOR

UH Limoges

Sebastien Fournier-Favre, MD

Role: PRINCIPAL_INVESTIGATOR

UH Monptellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UH Bordeaux

Bordeaux, , France

Site Status

UH Limoges

Limoges, , France

Site Status

UH Montpellier

Montpellier, , France

Site Status

UH Toulouse

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

08 030 08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.